Clinical Trial Update: Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Levotofisopam 50 mg three times daily for 7 days in patients with hyperuricemia and gout. The study status is currently UNKN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• Levotofisopam (Levotofisopam)

Snippet

Sponsor: Pharmos | Conditions: Hyperuricemia, Gout | Phase 2 | Status: UNKNOWN